Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion

Oncogene

Volumn 31, Issue 21, 2012, Pages 2691-2702

  Feng, H ^a   Liu, K W ^a   Guo, P ^a,b   Zhang, P ^c   Cheng, T ^c,d   McNiven, M A ^e   Johnson, G R ^f   Hu, B ^a,c   Cheng, S Y ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d PEKING UNION MEDICAL COLLEGE   (China)

^e MAYO GRADUATE SCHOOL   (United States)

^f Center for Drug Evaluation and Research   (United States)

Author keywords

Dyn2; glioma tumor growth; invasion; PDGFRa; SHP 2; Src

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DYNAMIN II; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN CDC42; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAC1 PROTEIN; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLINE RICH PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SRC HOMOLOGY DOMAIN; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; DISEASE PROGRESSION; DYNAMIN II; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, SRC; GLIOBLASTOMA; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SIGNAL TRANSDUCTION;

MUS;

EID: 84861523133     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.436     Document Type: Article

References (42)

1. Baldassarre M, Pompeo A, Beznoussenko G, Castaldi C, Cortellino S, McNiven MA et al. (2003). Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell 14: 1074-1084. (Pubitemid 36337453)
2. Boyle SN, Michaud GA, Schweitzer B, Predki PF, Koleske AJ. (2007). A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol 17: 445-451.
3. Calzolari F, Malatesta P. (2010). Recent insights into PDGF-induced gliomagenesis. Brain Pathol 20: 527-538.
4. Cao H, Chen J, Krueger EW, McNiven MA. (2010). SRC-mediated phosphorylation of dynamin and cortactin regulates the "constitutive" endocytosis of transferrin. Mol Cell Biol 30: 781-792.
5. Cao H, Garcia F, McNiven MA. (1998). Differential distribution of dynamin isoforms in mammalian cells. Mol Biol Cell 9: 2595-2609. (Pubitemid 28425896)
6. Carver KC, Piazza TM, Schuler LA. (2010). Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells. J Biol Chem 285: 8003-8012.
7. Cerami E, Demir E, Schultz N, Taylor BS, Sander C. (2010). Automated network analysis identifies core pathways in glioblastoma. PLoS One 5: e8918.
8. Chan G, Kalaitzidis D, Neel BG. (2008). The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev 27: 179-192.
9. Coyne CB, Kim KS, Bergelson JM. (2007). Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2. EMBO J 26: 4016-4028. (Pubitemid 47367499)
10. Damke H, Baba T, Warnock DE, Schmid SL. (1994). Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol 127: 915-934. (Pubitemid 24355982)
11. Furnari FB, Fenton T, Bachoo RM,Mukasa A, Stommel JM, Stegh A et al. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710. (Pubitemid 350070717)
12. Giese A, Bjerkvig R, Berens ME, Westphal M. (2003). Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624-1636. (Pubitemid 46594118)
13. Gold ES, Underhill DM, Morrissette NS, Guo J, McNiven MA, Aderem A. (1999). Dynamin 2 is required for phagocytosis in macrophages. J Exp Med 190: 1849-1856. (Pubitemid 30013850)
14. Gout I, Dhand R, Hiles ID, Fry MJ, Panayotou G, Das P et al. (1993). The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75: 25-36. (Pubitemid 23306018)
15. Haberler C, Gelpi E, Marosi C, Rossler K, Birner P, Budka H et al. (2006). Immunohistochemical analysis of platelet-derived growth factor receptor-alpha,-beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy. J Neurooncol 76: 105-109. (Pubitemid 43125736)
16. Imanishi Y, Hu B, JarzynkaMJ, Guo P, Elishaev E, Bar-Joseph I et al. (2007). Angiopoietin-2 stimulates breast cancer metastasis through the {alpha}5{beta}1 integrin-mediated pathway. Cancer Res 67: 4254-4263. (Pubitemid 46815072)
17. Jemal A, Siegel R, Xu J, Ward E. (2010). Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
18. Joshi S, Perera S, Gilbert J, Smith CM, Mariana A, Gordon CP et al. (2010). The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells. Mol Cancer Ther 9: 1995-2006.
19. Kawada K, Upadhyay G, Ferandon S, Janarthanan S, Hall M, Vilardaga JP et al. (2009). Cell migration is regulated by platelet-derived growth factor receptor endocytosis. Mol Cell Biol 29: 4508-4518.
20. Kowalski JR, Egile C, Gil S, Snapper SB, Li R, Thomas SM. (2005). Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 118: 79-87. (Pubitemid 40277106)
21. Kruchten AE, McNiven MA. (2006). Dynamin as a mover and pincher during cell migration and invasion. J Cell Sci 119: 1683-1690. (Pubitemid 43810995)
22. Krueger EW, Orth JD, Cao H, McNiven MA. (2003). A dynamincortactin-Arp2/3 complex mediates actin reorganization in growth factor-stimulated cells. Mol Biol Cell 14: 1085-1096. (Pubitemid 36337454)
23. Lee E, De Camilli P. (2002). Dynamin at actin tails. Proc Natl Acad Sci USA 99: 161-166. (Pubitemid 34060334)
24. Liu KW, Feng H, Bachoo R, Kazlauskas A, Smith EM, Symes K et al. (2011). SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J Clin Invest 121: 905-917.
25. Matozaki T, Murata Y, Saito Y, Okazawa H, Ohnishi H. (2009). Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation. Cancer Sci 100: 1786-1793.
26. McNiven MA, Cao H, Pitts KR, Yoon Y. (2000a). The dynamin family of mechanoenzymes: pinching in new places. Trends Biochem Sci 25: 115-120. (Pubitemid 30122422)
27. McNiven MA, Kim L, Krueger EW, Orth JD, Cao H, Wong TW. (2000b). Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J Cell Biol 151: 187-198.
28. Mitola S, Brenchio B, Piccinini M, Tertoolen L, Zammataro L, Breier G et al. (2006). Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. Circ Res 98: 45-54. (Pubitemid 43970202)
29. Navis AC, van den Eijnden M, Schepens JT, Hooft van Huijsduijnen R, Wesseling P, Hendriks WJ. (2010). Protein tyrosine phosphatases in glioma biology. Acta Neuropathol 119: 157-175.
30. Neel BG, Gu H, Pao L. (2003). The 'Shp'ing news: SH2 domaincontaining tyrosine phosphatases in cell signaling. Trends Biochem Sci 28: 284-293. (Pubitemid 36776291)
31. Ochoa GC, Slepnev VI, Neff L, Ringstad N, Takei K, Daniell L et al. (2000). A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol 150: 377-389. (Pubitemid 30491360)
32. Orth JD, McNiven MA. (2003). Dynamin at the actin-membrane interface. Curr Opin Cell Biol 15: 31-39. (Pubitemid 36044712)
33. Scaife R, Gout I, Waterfield MD, Margolis RL. (1994). Growth factor-induced binding of dynamin to signal transduction proteins involves sorting to distinct and separate proline-rich dynamin sequences. EMBO J 13: 2574-2582. (Pubitemid 24188390)
34. Schlunck G, Damke H, Kiosses WB, Rusk N, Symons MH, Waterman-Storer CM et al. (2004). Modulation of Rac localization and function by dynamin. Mol Biol Cell 15: 256-267. (Pubitemid 38044961)
35. Tallquist M, Kazlauskas A. (2004). PDGF signaling in cells and mice. Cytokine Growth Factor Rev 15: 205-213. (Pubitemid 38781046)
36. TCGA (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
37. van der Bliek AM, Redelmeier TE, Damke H, Tisdale EJ, Meyerowitz EM, Schmid SL. (1993). Mutations in human dynamin block an intermediate stage in coated vesicle formation. J Cell Biol 122: 553-563. (Pubitemid 23226673)
38. Waters CM, Connell MC, Pyne S, Pyne NJ. (2005). c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. Cell Signal 17: 263-277. (Pubitemid 39371053)
39. Weller SG, Capitani M, Cao H, Micaroni M, Luini A, Sallese M et al. (2010). Src kinase regulates the integrity and function of the Golgi apparatus via activation of dynamin 2. Proc Natl Acad Sci USA 107: 5863-5868.
40. Wen PY, Kesari S. (2008). Malignant gliomas in adults. N Engl J Med 359: 492-507.
41. Wu H, Reynolds AB, Kanner SB, Vines R, Parsons JT. (1991). Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 11: 5113-5124. (Pubitemid 21895272)
42. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T et al. (2004). Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell 13: 341-355. (Pubitemid 38229807)